[{"notes_id":"1_1997","category":"8","subcategory":"0","title":"Gentamicin","body":"Gentamicin is a type of aminoglycoside antibiotic. It is poorly lipid-soluble and is therefore given parentally (e.g. for infective endocarditis) or topically (e.g. for otitis externa).<br \/><br \/>Adverse effects<br \/><ul><li><span class=\"concept\" data-cid=\"1178\">ototoxicity<\/span><ul><li>due to auditory or vestibular nerve damage<\/li><li>irreversible<\/li><\/ul><\/li><li><span class=\"concept\" data-cid=\"2335\">nephrotoxicity<\/span><ul><li>accumulates in renal failure<\/li><li>gentamicin is preferentially taken up by the <span class=\"concept\" data-cid=\"12170\">proximal renal tubular cells<\/span>. Once inside these cells, it can accumulate to toxic levels<\/li><li>the toxicity is secondary to <span class=\"concept\" data-cid=\"10648\">acute tubular necrosis<\/span><\/li><li>concomitant use of <span class=\"concept\" data-cid=\"5833\">furosemide increases the risk<\/span><\/li><li>lower doses and more frequent monitoring is required<\/li><\/ul><\/li><\/ul><br \/>Contraindications<br \/><ul><li>myasthenia gravis<\/li><\/ul><br \/>Dosing<br \/><ul><li>due to the significant ototoxic and nephrotoxic potential of gentamicin it is important to monitor plasma concentrations<\/li><li>both peak (1 hour after administration) and trough levels (just before the next dose) are measured<\/li><li>if the trough (pre-dose) level is high the interval between the doses should be increased<\/li><li>if the peak (post-dose) level is high the dose should be decreased<\/li><\/ul>","notes_hash":"2b306bae86dad9f9b15333df934ce0e5","knowledge_graph_node_id_link":0,"links":"","media":"","concepts_for_notes":{"1178":{"concept_text":"An important adverse effect of aminoglycosides is ototoxicity","concept_percentile":"75"},"2335":{"concept_text":"Aminoglycosides are nephrotoxic","concept_percentile":"66"}},"category_name":"Pharmacology and therapeutics","subcategory_name":"","comment_count":4},"",[]]